Diabetes mellitus - risk factor for atrial fibrillation. Potential therapeutic implications

被引：0
|
作者：
Meinertz, T. [1 ]
Sydow, K. [2 ]
机构：
[1] Deutsch Herzstiftung, D-60322 Frankfurt, Germany
[2] Univ Herzzentrum Hamburg, Hamburg, Germany
来源：
HERZ | 2014年 / 39卷 / 03期
关键词：
Metabolic disorder; Glycemic control; Cardiac arrhythmia; Cardiovascular events; Prognosis; METABOLIC SYNDROME; PREVALENCE; OBESITY; COHORT; ADULTS; IMPACT;
D O I：
10.1007/s00059-014-4085-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The relationship between atrial fibrillation and diabetes mellitus type 2 is controversial, and various studies have demonstrated conflicting results. However, the majority of larger prospective studies published during recent years demonstrated a positive correlation. After multivariate adjustment diabetes increased the risk for atrial fibrillation at least two fold. This combination is associated with substantially increased risks of death and cardiovascular events (stroke and heart failure). Atrial fibrillation in patients with diabetes mellitus type 2 identifies individuals who are likely to obtain greater benefits from glycemic control and anticoagulants as well as antihypertensive therapy.
引用
收藏
页码：320 / 324
页数：5
相关论文
共 50 条
  • [21] Potential Pharmacological Therapies for Atrial Fibrillation. A Computational Study
    Sanchez, C.
    Corrias, A.
    Laguna, P.
    Davies, M.
    Swinton, J.
    Jacobson, I.
    Pueyo, E.
    Rodriguez, B.
    COMPUTING IN CARDIOLOGY 2010, VOL 37, 2010, 37 : 413 - 416
  • [22] Inflammation: Another potential mechanism between diabetes mellitus and atrial fibrillation
    Liu, Tong
    Li, Guangping
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (11): : 1681 - 1682
  • [23] Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies
    Goudis, Christos A.
    Korantzopoulos, Panagiotis
    Ntalas, Ioannis V.
    Kallergis, Eleftherios M.
    Liu, Tong
    Ketikoglou, Dimitrios G.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 184 : 617 - 622
  • [24] Catgeter ablation of atrial fibrillation. An update of current therapeutic options
    Drewitz, I.
    Rostock, T.
    Hoffmann, B. A.
    Steven, D.
    Meinertz, T.
    Willems, S.
    KARDIOLOGE, 2010, 4 (03): : 214 - 225
  • [25] Incidence and risk factors for ibrutinib associated atrial fibrillation.
    Emole, Josephine Ngozi
    Viganego, Federico
    Schabath, Matthew B.
    Shah, Bijal D.
    Chavez, Julio C.
    Walko, Christine Marie
    McLeod, Howard L.
    Pinilla-Ibarz, Javier
    Fradley, Michael G.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] Electrophysiological remodelling induced by atrial fibrillation an experimental curiosity or a major factor in clinical atrial fibrillation.
    Piot, O
    Paziaud, O
    Digeos, S
    Copie, X
    Lavergne, T
    Guize, L
    Le Heuzey, JY
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2000, 93 (07): : 841 - 848
  • [27] Prognostic implications of myocardial perfusion SPECT in patients with atrial fibrillation.
    Santos, MM
    Abidov, A
    Hayes, SW
    Sciammarella, MG
    Cohen, I
    Gerlach, JR
    Germano, G
    Friedman, JD
    Berman, DS
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 98P - 98P
  • [28] Atrial Structural Remodeling is Progressive Following Exposure to Nicotine: Implications for Atrial Fibrillation.
    Rangnekar, Geetanjali
    Chakrabarty, Adhiraj
    Sanders, Prashanthan
    Mackenzie, Lorraine
    CIRCULATION, 2010, 122 (21)
  • [29] Type 2 Diabetes Mellitus and Risk of Incident Atrial Fibrillation in Women
    Schoen, Tobias
    Pradhan, Aruna D.
    Albert, Christine M.
    Conen, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (15) : 1421 - 1428
  • [30] CARDIOMETABOLIC RISK FACTORS FOR ATRIAL FIBRILLATION IN TYPE 2 DIABETES MELLITUS
    Gaman, M.
    Dobrica, E. C.
    Pascu, E. G.
    Cozma, M. A.
    Epingeac, M. E.
    Gaman, A. M.
    Diaconu, C. C.
    JOURNAL OF HYPERTENSION, 2019, 37 : E96 - E96
12345